title: Comment on: "EU's new pharmacovigilance legislation: considerations for biosimilars".
authors: Medicines Authority, 203 Level 3, Rue D'Argens, Gzira, GZR 1368, Malta, john-joseph.borg@gov.mt.
authors: John Joseph
authors: JJ
authors: Borg
authors: Anthony
authors: A
authors: Serracino-Inglott
authors: Lilian M
authors: LM
authors: Azzopardi
authors: Christian K
authors: CK
authors: Schneider
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D060735:Pharmacovigilance
chemical_list: D059451:Biosimilar Pharmaceuticals